HSMN NewsFeed via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'HSMN NewsFeed' source. Thu, 09 Feb 2012 01:31:32 +0100 Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida http://www.medworm.com/index.php?rid=5661337&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034462 DUBLIN, Ohio, Feb. 3, 2012 (HSMN NewsFeed) -- Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration's (DEA) immediate suspension order of its Lakeland, Fla. DEA registration. U.S. District Court fo... Biopharmaceuticals, DistributionCardinal Health (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5661337 Sat, 04 Feb 2012 04:00:00 +0100 5661337 Prometheus Announces New Chief Commercial Officer http://www.medworm.com/index.php?rid=5661338&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034461 SAN DIEGO, Feb. 3, 2012 (HSMN NewsFeed) -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the appointment of Anthony J. Yost as Senior Vice President and Chief Commercial Officer. Tony joins Prometheus... Diagnostics, PersonnelPrometheus Laboratories (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5661338 Fri, 03 Feb 2012 13:25:33 +0100 5661338 Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302 http://www.medworm.com/index.php?rid=5661339&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034460 * Threshold to receive $25 million upfront, plus further potential milestones and royalties * Deal provides Threshold option to co-commercialize in the United States * Phase 3 trial in soft tissue sarcoma on-going and randomized Phase II trial in pat... Biopharmaceuticals, OncologyThreshold Pharmaceuticals, Merck KGaA, TH-302, soft tissue sarcoma (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5661339 Fri, 03 Feb 2012 12:45:03 +0100 5661339 Caris Diagnostics Announces Name Change to Miraca Life Sciences http://www.medworm.com/index.php?rid=5661340&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034459 Company to Provide Same High-Quality Anatomic Pathology Services Under New Name TOKYO and IRVING, Texas, Feb. 3, 2012 --(HSMN NewsFeed) -- Caris Diagnostics, specializing in academic-caliber anatomic pathology services, today announced a company name ch... DiagnosticsMiraca Life Sciences, Caris Diagnostics (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5661340 Fri, 03 Feb 2012 12:39:31 +0100 5661340 Ronnie Andrews Joins Life Technologies as President, Medical Sciences http://www.medworm.com/index.php?rid=5651488&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034458 Leveraging 25-Plus Years Diagnostic Industry Experience, Andrews Will Shape Life Technologies Molecular Diagnostics Business CARLSBAD, Calif., Feb. 2, 2012 (HSMN NewsFeed) -- Life Technologies Corporation (NASDAQ: LIFE ) today announced that Ronnie An... Diagnostics, PersonnelLife Technologies (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5651488 Thu, 02 Feb 2012 13:14:54 +0100 5651488 Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis http://www.medworm.com/index.php?rid=5651489&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034457 Results Provide Basis for Landmark EXCITE ISR Trial Underway in United States COLORADO SPRINGS, Colo.--(Healthcare Sales & Marketing Network)-- Spectranetics Corporation (Nasdaq:SPNC ) today announced six month interim results from the PATENT (Photo-Abl... Devices, InterventionalSpectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5651489 Thu, 02 Feb 2012 12:59:10 +0100 5651489 Syneron Announces New Ground Breaking evolastin(TM) Procedure http://www.medworm.com/index.php?rid=5661341&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034456 One treatment procedure primed to propel facial aesthetic procedures forward with unique results and significant science IRVINE, Calif., Feb. 2, 2012 (HSMN NewsFeed) -- Syneron Medical Ltd. (NASDAQ: ELOS ), www.syneron.com, the global leader in medica... Devices, DermatologySyneron Medical, evolastin procedure (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5661341 Thu, 02 Feb 2012 12:55:22 +0100 5661341 Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone http://www.medworm.com/index.php?rid=5631176&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034411 NORTHVALE, N.J., Jan. 26, 2012 --(HSMN NewsFeed) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP.OB ) announced today that on January 23, 2012, the U.S. Food and Drug Administration approved the Company's supplemental application for the man... Biopharmaceuticals, FDAElite Pharmaceuticals, Hydromorphone (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5631176 Thu, 26 Jan 2012 16:57:54 +0100 5631176 Amgen to Acquire Micromet http://www.medworm.com/index.php?rid=5631177&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034410 Acquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies Micromet's Proprietary BiTE® Platform has Potential to Improve Treatment in Multiple Tumor Types All-Cash Transaction Values Micromet at $1.16 Billion ... Biopharmaceuticals, Oncology, Mergers & AcquisitionsAmgen, Micromet , Blinatumomab (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5631177 Thu, 26 Jan 2012 16:55:14 +0100 5631177 Varian Medical Systems Books $77 Million Order to Equip Proton Treatment Center in Saudi Arabia http://www.medworm.com/index.php?rid=5631178&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034409 PALO ALTO, Calif., Jan. 26, 2012 (HSMN NewsFeed) -- Varian Medical Systems (NYSE: VAR ) today announced it has booked a $77 million order with Saudi Particle Therapy Centre LLC to equip a new proton therapy facility at the King Fahd Medical Center in Riy... Devices, OncologyVarian Medical Systems, TrueBeam, radiotherapy, ProBeam, proton therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5631178 Thu, 26 Jan 2012 16:49:58 +0100 5631178 Guided Therapeutics Provides Update on PMA Application for LuViva(R) Advanced Cervical Scan and Timing for Filing of CE Mark http://www.medworm.com/index.php?rid=5612224&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034378 Company to Host Conference Call with Investors on January 23 at 10 A.M. EST NORCROSS, Ga.--(Healthcare Sales & Marketing Network)-- Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced that the company plans to seek an independent panel revie... Devices, Diagnostics, Oncology, FDA, RegulatoryGuided Therapeutics, LuViva, Advanced Cervical Scan, cervical cancer (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5612224 Fri, 20 Jan 2012 23:25:36 +0100 5612224 NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product http://www.medworm.com/index.php?rid=5612225&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034377 BRIDGEWATER, N.J.--(Healthcare Sales & Marketing Network)-- NovaDel Pharma Inc. (OTCBB: NVDL.OB ), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced the termination of certain lice... Biopharmaceuticals, Drug Delivery, LicensingNovaDel Pharma, Talon Therapeutics, Par Pharmaceutical, ondansetron (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5612225 Fri, 20 Jan 2012 23:20:43 +0100 5612225 Quest Diagnostics STRATIFY JCV(TM) First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients http://www.medworm.com/index.php?rid=5612226&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034376 Based on exclusive collaboration with Biogen Idec, the test is only available in the U.S. through Quest Diagnostics' Focus Diagnostics lab MADISON, N.J., Jan. 20, 2012 (HSMN NewsFeed) -- Quest Diagnostics (NYSE: DGX ), the world's leading provider of ... Diagnostics, Neurology, Personalized Medicine, FDAQuest Diagnostics, STRATIFY JCV, PML, multiple sclerosis, TYSABRI, natalizumab (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5612226 Fri, 20 Jan 2012 23:17:51 +0100 5612226 Remicade(R) (Infliximab) Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients http://www.medworm.com/index.php?rid=5612227&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034375 Positive Opinion Recommends Approval of the First and Only Anti-TNF Therapy in Pediatric Patients with Severely Active Ulcerative Colitis, a Chronic, Inflammatory Bowel Disease WHITEHOUSE STATION, N.J.--(Healthcare Sales & Marketing Network)-- MSD (also... Biopharmaceuticals, Gastroenterology, RegulatoryMerck, REMICADE, infliximab, ulcerative colitis (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5612227 Fri, 20 Jan 2012 17:04:57 +0100 5612227 Ventrus Appoints New Board Member http://www.medworm.com/index.php?rid=5612228&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034374 NEW YORK, Jan. 20, 2012 --(HSMN NewsFeed) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS ), today announced the appointment of Anthony E. Altig to its board of directors. Mr. Altig is the Chief Financial Officer of Biotix Holdings, Inc. a company that manufa... Biopharmaceuticals, PersonnelVentrus BioSciences (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5612228 Fri, 20 Jan 2012 16:51:15 +0100 5612228 Cytomedix Appoints Cathryn Hope as Vice President of Marketing http://www.medworm.com/index.php?rid=5600116&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034348 GAITHERSBURG, MD--(Healthcare Sales & Marketing Network)- Cytomedix, Inc. (OTC.BB: CMXI.OB ) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the app... Regenerative Medicine, PersonnelCytomedix (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5600116 Wed, 18 Jan 2012 01:14:34 +0100 5600116 Hansen Medical to Highlight Sensei(R) X Robotic Catheter System and Related Products at the Boston Atrial Fibrillation Symposium http://www.medworm.com/index.php?rid=5573516&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034316 Company to Demonstrate Its Advanced Catheter Control With 3D Visualization, and Advanced Training Programs MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network)- Hansen Medical, Inc. (NASDAQ: HNSN ), a global leader in flexible catheter robotics and... Devices, CardiologyHansen Medical, Sensei, Robotic Catheter System, Atrial Fibrillation (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5573516 Fri, 06 Jan 2012 22:17:19 +0100 5573516 Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA(R) http://www.medworm.com/index.php?rid=5573517&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034315 EAST BRUNSWICK, N.J. , Jan. 6, 2012 (HSMN NewsFeed) --Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) today announced that a product-specific billing code, or permanent J-code, for KRYSTEXXA® (pegloticase) became available on January 1, 2012 . The new ... Biopharmaceuticals, ReimbursementSavient Pharmaceuticals, KRYSTEXXA, pegloticase, gout (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5573517 Fri, 06 Jan 2012 21:54:47 +0100 5573517 China Kanghui Holdings Receives FDA Approvals for Hip and Knee Systems http://www.medworm.com/index.php?rid=5573518&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034314 CHANGZHOU, China , Jan. 6, 2012 Healthcare Sales & Marketing Network -- China Kanghui Holdings (NYSE: KH ) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China , today ann... Devices, Orthopaedic, FDAChina Kanghui Holdings, TGM Medical, Helicon Hip System, Milestone Knee System (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5573518 Fri, 06 Jan 2012 12:54:23 +0100 5573518 FDA Clears PICO* Single Use Negative Pressure Wound Therapy System From Smith and Nephew, Expanding Patient Access http://www.medworm.com/index.php?rid=5573519&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034313 ST. PETERSBURG, Fla. , Jan. 6, 2012 (HSMN NewsFeed) -- Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces the FDA clearance of the pocket-sized PICO* system, a single use Negative Pressure Wound Therapy (NPWT) syst... Devices, Wound Care, FDASmith & Nephew, PICO system, Negative Pressure Wound Therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5573519 Fri, 06 Jan 2012 12:49:27 +0100 5573519 Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine http://www.medworm.com/index.php?rid=5573520&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034312 CHADDS FORD, Pa. , Jan. 6, 2012 (HSMN NewsFeed) -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today it has signed a worldwide license and development agreement with U.S.-based BioDelivery Sciences International (Nasdaq: BDSI ) for BEMA Buprenorphine.... Biopharmaceuticals, Drug Delivery, LicensingEndo Pharmaceuticals, BioDelivery Sciences International, BEMA Buprenorphine (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5573520 Fri, 06 Jan 2012 12:44:46 +0100 5573520 BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine http://www.medworm.com/index.php?rid=5573521&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034311 BDSI to receive up to $180 million plus royalties BDSI management to hold conference call on Friday, Jan. 6, 2012, at 8:30 A.M. EST RALEIGH, N.C. , Jan. 6, 2012 (HSMN NewsFeed) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI ) today annou... Biopharmaceuticals, Drug Delivery, LicensingBioDelivery Sciences Internationa, Endo Pharmaceuticals, BEMA Buprenorphine (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5573521 Fri, 06 Jan 2012 12:41:45 +0100 5573521 Biomerix Receives CE Mark Approval For ASSURE Soft Tissue Repair Mesh http://www.medworm.com/index.php?rid=5562892&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034310 Incorporating the Biomerix Biomaterial, an innovative synthetic tissue scaffold FREMONT, Calif. , Jan. 5, 2012 (HSMN NewsFeed) -- Biomerix Corporation announced today that it has received CE Mark approval for its ASSURE soft tissue repair mesh, a nov... Devices, Surgery, Regenerative Medicine, RegulatoryBiomerix, Biomerix Biomaterial, soft tissue repair mesh (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5562892 Thu, 05 Jan 2012 16:05:12 +0100 5562892 Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Surgical Endoscopy and Video Equipment http://www.medworm.com/index.php?rid=5553981&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034277 CHARLOTTE, N.C.--(Healthcare Sales & Marketing Network)-- The Premier healthcare alliance today announced new agreements for surgical endoscopy and video equipment have been awarded to Olympus America, Inc. and Gyrus ACMI, LP of Center Valley, Pa.; and Str... Devices, Group PurchasingPremier Purchasing, Olympus America, Gyrus ACMI, Stryker (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5553981 Fri, 30 Dec 2011 13:51:28 +0100 5553981 MindFrame Inc Announces CE Mark for New Capture(TM) LP Devices for Treatment of Patients Experiencing Ischemic Stroke http://www.medworm.com/index.php?rid=5553982&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034276 First and Only 4-mm Thrombectomy Devices That Can Be Deployed Through Catheters as Small as 10/14 Offer Improved Navigation and Aspiration IRVINE, Calif.--(Healthcare Sales & Marketing Network)-- MindFrame, Inc. today announces that a CE mark was grante... Devices, Interventional, RegulatoryMindFrame, Capture LP, thrombectomy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5553982 Thu, 29 Dec 2011 15:14:52 +0100 5553982 Gentium Provides Update on MAA Process for Defibrotide in Europe http://www.medworm.com/index.php?rid=5553983&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034274 VILLA GUARDIA, Italy, Dec. 29, 2011 --(HSMN NewsFeed) -- Gentium S.p.A. (Nasdaq:GENT ) (the "Company") today provided an update on the European Marketing Authorization Application for Defibrotide (the "MAA") to treat and prevent hepatic... Biopharmaceuticals, RegulatoryGentium, Defibrotide, veno-occlusive disease (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5553983 Thu, 29 Dec 2011 12:47:09 +0100 5553983 KCI Announces Transition to New Executive Leadership http://www.medworm.com/index.php?rid=5553984&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034275 SAN ANTONIO--(Healthcare Sales & Marketing Network)-- The Board of Directors of the parent company for Kinetic Concepts, Inc. today announced the completion of the transition responsibilities of Catherine M. Burzik, President and Chief Executive Officer of... Devices, Wound Care, PersonnelKinetic Concepts, KCI (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5553984 Thu, 29 Dec 2011 04:00:00 +0100 5553984 PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund http://www.medworm.com/index.php?rid=5553985&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034273 Founders Fund Partner and PayPal Co-Founder, Ken Howery Joins PharmacoFore's Board of Directors SAN CARLOS, Calif. , Dec. 27, 2011 (HSMN NewsFeed) -- PharmacoFore, Inc., a privately held biopharmaceutical company, today announced a $10 million round o... Biopharmaceuticals, Venture Capital, PersonnelPharmacoFore (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5553985 Wed, 28 Dec 2011 04:00:00 +0100 5553985 GenVec President and Chief Executive Officer Announces Retirement http://www.medworm.com/index.php?rid=5496990&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034233 Paul H. Fischer Will Serve Until Successor is Named, Board of Directors Initiates Search GAITHERSBURG, Md. , Dec. 13, 2011 (HSMN NewsFeed) -- GenVec, Inc. (Nasdaq: GNVC ), a biopharmaceutical company using differentiated, proprietary technologies to c... Biopharmaceuticals, PersonnelGenVec (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496990 Tue, 13 Dec 2011 13:17:28 +0100 5496990 Baxter Signs Definitive Agreement to Acquire Synovis http://www.medworm.com/index.php?rid=5496991&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034232 DEERFIELD, Ill. & ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)-- Baxter International Inc. (NYSE:BAX ) and Synovis Life Technologies, Inc. (NASDAQ:SYNO ) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of... Devices, Surgery, Mergers & AcquisitionsBaxter, Synovis Life Technologies (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496991 Tue, 13 Dec 2011 13:14:35 +0100 5496991 EnteroMedics Receives First Approval for the Active Implantable Medical Device Components of the Maestro System From Australian Therapeutic Goods Administration (TGA) http://www.medworm.com/index.php?rid=5496992&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034231 Review of Remaining Components Continues ST. PAUL, MN--(Healthcare Sales & Marketing Network)- EnteroMedics Inc. (NASDAQ: ETRM ), the developer of medical devices using neuroblocking technology to treat obesity, metabolic disease and other gastrointesti... Devices, RegulatoryEnteroMedics, Maestro System, VBLOC Therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496992 Tue, 13 Dec 2011 13:11:27 +0100 5496992 Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing http://www.medworm.com/index.php?rid=5496993&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034230 New Funding to Expedite Development of CAT-2003 Program in Severe Hypertriglyceridemia CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)-- Catabasis Pharmaceuticals, a biopharmaceutical company leveraging the therapeutic potential of omega-3 fatt... Biopharmaceuticalas, Venture CapitalCatabasis Pharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496993 Tue, 13 Dec 2011 13:05:50 +0100 5496993 Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery http://www.medworm.com/index.php?rid=5496994&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034229 Pooled results of the STARS E-III and STARS J-V studies presented at the 2011 American Society of Hematology (ASH) Annual Meeting MUNICH , December 13, 2011 (HSMN NewsFeed) -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced... BiopharmaceuticalsDaiichi Sankyo, edoxaban, venous thromboembolism (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496994 Tue, 13 Dec 2011 13:02:38 +0100 5496994 Medtronic Reaches Settlement with United States Department of Justice http://www.medworm.com/index.php?rid=5496995&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034228 MINNEAPOLIS--(Healthcare Sales & Marketing Network)-- Medtronic, Inc. (NYSE: MDT ) today announced that the Company has reached a settlement agreement with the United States Department of Justice (DOJ) regarding a previously disclosed industry-wide review ... Devices, CardiologyMedtronic, pacemaker, defibrillator (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496995 Tue, 13 Dec 2011 04:46:35 +0100 5496995 Pfizer Elects CEO Ian Read As Chairman Of The Board http://www.medworm.com/index.php?rid=5496996&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034227 Two New Directors Elected to Pfizer Board Marc Tessier-Lavigne, Ph.D. and Helen Hobbs, M.D. George Lorch Named Lead Independent Director NEW YORK--(Healthcare Sales & Marketing Network)-- Pfizer Inc. (NYSE: PFE ) today announced that its Board of... Biopharmaceuticals, PersonnelPfizer (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5496996 Tue, 13 Dec 2011 04:44:28 +0100 5496996 AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations http://www.medworm.com/index.php?rid=5489161&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034219 New Hire Is Part of Organizational Restructuring Focused on Improving Operational Efficiencies BOTHELL, WA--(Healthcare Sales & Marketing Network)- AVI BioPharma, Inc. (NASDAQ: AVII ), a developer of RNA-based therapeutics, today announced the appointme... Biopharmaceuticals, PersonnelAVI BioPharma (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5489161 Fri, 09 Dec 2011 15:22:42 +0100 5489161 Immunomedics Creates Targeted Therapeutics for Solid Cancers http://www.medworm.com/index.php?rid=5489162&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034218 Novel Agents Constructed Using the Company's Patented Dock-and-Lock Method SAN ANTONIO, Dec. 9, 2011 --(HSMN NewsFeed) -- Immunomedics, Inc. (Nasdaq:IMMU ), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based pr... Biopharmaceuticals, OncologyImmunomedics, monoclonal antibody, Dock-and-Lock (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5489162 Fri, 09 Dec 2011 15:19:58 +0100 5489162 Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium http://www.medworm.com/index.php?rid=5489163&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034217 BRACAnalysis Test is Cost-Effective for Unaffected Patients With a Family History of Breast and/or Ovarian Cancer SALT LAKE CITY, Dec. 9, 2011 --(HSMN NewsFeed) -- Myriad Genetics, Inc. (Nasdaq:MYGN ) announced today that a presentation entitled "C... Diagnostics, OncologyMyriad Genetics, BRACAnalysis , BRCA1, breast cancer (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5489163 Fri, 09 Dec 2011 15:16:55 +0100 5489163 Bluegrass Vascular Technologies Begins First Clinical Study of the Surfacer(TM) Inside-Out Access Catheter System http://www.medworm.com/index.php?rid=5489164&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034216 LEXINGTON, Ky.--(Healthcare Sales & Marketing Network)-- Bluegrass Vascular Technologies, a medical technology company focused on life-saving devices and methods for vascular access procedures, has announced patient enrollment in the first clinical study o... DevicesBluegrass Vascular Technologies, Surfacer, Inside-Out Access Catheter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5489164 Fri, 09 Dec 2011 15:11:07 +0100 5489164 Icon Appoints Murahashi Vice President, Clinical Development http://www.medworm.com/index.php?rid=5478961&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034208 SUNNYVALE, Calif. , Dec. 7, 2011 (HSMN NewsFeed) -- Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals, today announced that Wendy Yee Mur... Biopharmaceuticals, Drug Delivery, PersonnelIcon Bioscience, Verisome (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5478961 Wed, 07 Dec 2011 17:20:38 +0100 5478961 HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as President and CEO http://www.medworm.com/index.php?rid=5478962&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034207 NEW YORK and PITTSBURGH , Dec. 7, 2011 (HSMN NewsFeed) -- HealthpointCapital, LLC ("HealthpointCapital") announced today the purchase of Blue Belt Technologies, Inc. ("Blue Belt" or "Company"). Blue Belt is developing the ne... Devices, Mergers & Acquisitions, Surgery, PersonnelHealthpointCapital, Blue Belt Technologies, Navio PFS (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5478962 Wed, 07 Dec 2011 12:40:54 +0100 5478962 Missouri Baptist Medical Center Physicians Are First in Missouri to Implant New Heart Failure Device http://www.medworm.com/index.php?rid=5470667&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034184 ST. LOUIS, MO -- (Healthcare Sales & Marketing Network) -- Cardiologists at Missouri Baptist Medical Center, one of Missouri's leading heart centers, were the first in the state to implant a new type of cardiac resynchronization therapy defibrillator (CRT-... Devices, CardiologySt. Jude Medical, cardiac resynchronization therapy, CRT-D, quadripolar pacing (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5470667 Fri, 02 Dec 2011 17:46:47 +0100 5470667 AccuVein Vein Illumination Becoming Standard of Care With Purchase of 64 AV300 Units by Banner Health http://www.medworm.com/index.php?rid=5460670&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034179 AV300 Units Now in Use at 10 Banner Health Facilities LONG ISLAND, N.Y., Dec. 1, 2011 --(HSMN NewsFeed) -- AccuVein Inc., a global leader in medical imaging technology and the creator of the AV300, the world's only hand-held, non-contact vein illuminati... DevicesAccuVein, AV300, vein illumination device (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5460670 Thu, 01 Dec 2011 12:57:50 +0100 5460670 Covidien's Embolic Protection Device Receives FDA Clearance http://www.medworm.com/index.php?rid=5460671&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034178 SpiderFX® is the only device in the U.S. indicated for use in the lower extremities MANSFIELD, Mass.--(Healthcare Sales & Marketing Network)-- Covidien (NYSE: COV ), a leading global provider of healthcare products, today announced that the U.S. Foo... Devices, Interventional, FDACovidien, SpiderFX, embolic protection (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5460671 Thu, 01 Dec 2011 12:54:16 +0100 5460671 Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder Syndrome http://www.medworm.com/index.php?rid=5460672&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034177 Phase IIa Dose-Ranging Study Will Measure Safety and Efficacy of XIAFLEX for Treatment of Frozen Shoulder Syndrome MALVERN, Pa. , Dec. 1, 2011 (HSMN NewsFeed) -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, to... BiopharmaceuticalsAuxilium Pharmaceuticals, XIAFLEX, Frozen Shoulder syndrome (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5460672 Thu, 01 Dec 2011 12:49:10 +0100 5460672 Texas Heart Institute and MicroMed Cardiovascular, Inc. Announce Achievement of World Record of an Animal Supported by an Electronic Total Artificial Heart http://www.medworm.com/index.php?rid=5460673&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034176 HOUSTON, TX--(Healthcare Sales & Marketing Network)- Texas Heart Institute and MicroMed Cardiovascular, Inc. announced today, during the opening of the 6th Annual European Mechanical Circulatory Support Summit in Paris, a new record has been established fo... Devices, CardiologyMicroMed Cardiovascular, Total Artificial Heart, HeartAssist 5, LVAD (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5460673 Thu, 01 Dec 2011 12:42:09 +0100 5460673 Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels http://www.medworm.com/index.php?rid=5460674&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034175 Increased Vitamin D Testing Volume Fueling Demand for Rapid, Automated Tests ABBOTT PARK, Ill., Nov. 30, 2011 (HSMN NewsFeed) -- Abbott (NYSE: ABT ) announced today it has received clearance from the U.S. Food and Drug Administration for a fully-autom... Diagnostics, FDAAbbott, Vitamin D assay (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5460674 Wed, 30 Nov 2011 13:14:50 +0100 5460674 Amarin Announces Resignation of David Feigal from Board of Directors http://www.medworm.com/index.php?rid=5443718&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034156 BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 25, 2011 --(HSMN NewsFeed) -- Amarin Corporation plc (Nasdaq:AMRN ), a late-stage biopharmaceutical company focused on cardiovascular disease, today announced that Dr. David Feigal has resigned as a member of the... Biopharmaceuticals, PersonnelAmarin Corp (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5443718 Fri, 25 Nov 2011 12:20:22 +0100 5443718 IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment http://www.medworm.com/index.php?rid=5433670&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034154 Revolutionary Therapy For Glioblastomas and Metastasized Brain Cancers RICHLAND, Wash.--(Healthcare Sales & Marketing Network)-- IsoRay, Inc. (Amex: ISR ) announced today it has received final approval from the State of Washington Department of Health t... Devices, OncologyIsoRay, GliaSite, radiation therapy, brain cancer (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5433670 Tue, 22 Nov 2011 12:59:44 +0100 5433670 Pfizer to Acquire Excaliard Pharmaceuticals http://www.medworm.com/index.php?rid=5433671&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034153 Lead Program Includes Novel Investigational Compound for Prevention/Treatment of Skin Scarring NEW YORK & SAN DIEGO--(Healthcare Sales & Marketing Network)-- Pfizer Inc. (NYSE: PFE ) and Excaliard Pharmaceuticals, Inc. announced today that they have ent... Biopharmaceuticals, Mergers & AcquisitionsPfizer, Excaliard (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5433671 Tue, 22 Nov 2011 12:56:04 +0100 5433671 Aptus Endosystems, Inc. Receives U.S. FDA Clearance For EndoStapling System http://www.medworm.com/index.php?rid=5433672&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034152 Breakthrough Aortic Aneurysm Repair Technology Approved for use with Market-Leading Endografts SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)-- Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular ... Devices, Interventional, FDAAptus Endosystems, Aptus EndoStapling System, HeliFX, Aortic Securement System (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5433672 Tue, 22 Nov 2011 01:43:28 +0100 5433672 BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien http://www.medworm.com/index.php?rid=5433673&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034151 SUNNYVALE, Calif. , Nov. 21, 2011 (HSMN NewsFeed) -- BARRX Medical Inc., a leader in developing minimally invasive medical devices used in conjunction with endoscopy to remove precancerous tissue from the gastrointestinal tract, announces today that they... Devices, Mergers & AcquisitionsBARRX Medical, Covidien, Barrett's esophagus (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5433673 Tue, 22 Nov 2011 01:37:42 +0100 5433673 EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia http://www.medworm.com/index.php?rid=5424377&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034144 First and only alternative for patients with hypersensitivity to standard-of-care treatment with E. coli-derived pegaspargase LANGHORNE, Pa. and OXFORD, England, Nov. 18, 2011 (HSMN NewsFeed) -- EUSA Pharma, a transatlantic specialty pharmaceutical c... Biopharmaceuticals, Oncology, FDAEUSA Pharma, ERWINAZE, asparaginase, acute lymphoblastic leukemia (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424377 Fri, 18 Nov 2011 15:29:38 +0100 5424377 Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi and Co., Ltd. http://www.medworm.com/index.php?rid=5424378&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034143 Shionogi and Shire to jointly develop and commercialize ADHD medicines in Japan NYON, Switzerland and PHILADELPHIA , November 18, 2011 (HSMN NewsFeed) -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces th... BiopharmaceuticalsShire plc, Shionogi & Co, ADHD (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424378 Fri, 18 Nov 2011 13:00:22 +0100 5424378 Cohera Medical Commercializes TissuGlu(R) Surgical Adhesive in Germany http://www.medworm.com/index.php?rid=5424379&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034142 Over 80 Plastic Surgery Procedures Successfully Performed with TissuGlu During Pre-Launch Period PITTSBURGH , Nov. 17, 2011 (HSMN NewsFeed) -- Cohera Medical, a rapidly growing medical device company, announced today that it has begun selling its lead... DevicesCohera Medical, TissuGlu, Surgical Adhesive (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424379 Thu, 17 Nov 2011 17:56:30 +0100 5424379 Agios Secures $78 Million in Oversubscribed Series C Financing http://www.medworm.com/index.php?rid=5424380&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034141 Round Includes Several Leading Public Investment Funds; Proceeds will Accelerate Cancer Metabolism Programs and Support Expansion into New Area of Dysregulated Metabolism CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)-- Agios Pharmaceuticals, ... Biopharmaceuticals, Oncology, Venture Capital, PersonnelAgios Pharmaceuticals, cancer metabolism (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424380 Thu, 17 Nov 2011 13:03:44 +0100 5424380 InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors http://www.medworm.com/index.php?rid=5424381&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034140 Founder of Celgene Agrees to Chair the Board TEL-AVIV, Israel , Nov. 17, 2011 (HSMN NewsFeed) -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), a medical device company focusing on the development and commercializatio... Devices, Interventional, PersonnelInspireMD, MGuard (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424381 Thu, 17 Nov 2011 12:59:10 +0100 5424381 Theralase Introduces Low Priced Laser Series http://www.medworm.com/index.php?rid=5424382&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034139 New TLC-900 Laser Series Offers Theralase's Renowned Clinical Performance at Lower Prices TORONTO, ONTARIO--(Healthcare Sales & Marketing Network)- Theralase Technologies Inc. (TSX-V: TLT.V ) announced today that it has launched a new version of the hig... DevicesTheralase Technologies, TLC-900 series, Low Level Laser Therapy, laser (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424382 Thu, 17 Nov 2011 12:56:39 +0100 5424382 SurgiCount Medical Announces Agreement with Premier Healthcare Alliance http://www.medworm.com/index.php?rid=5424383&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034138 IRVINE, Calif. , Nov. 17, 2011 (HSMN NewsFeed) -- SurgiCount Medical, Inc., the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTCBB: PSTX, OTCQB: PSTX) today announced that it has signed an agreement with the Premier healthcare ... Devices, Surgery, Group PurchasingSurgiCount Medical, Safety-Sponge (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5424383 Thu, 17 Nov 2011 12:52:33 +0100 5424383 Alphatec Spine Appoints New Senior Vice President, Global Marketing and Asia Pacific http://www.medworm.com/index.php?rid=5411869&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034135 Curt Jennewine, Seasoned Medical Device Marketing and Sales Executive, Agrees to Join Alphatec Spine CARLSBAD, Calif., Nov. 16, 2011 --(HSMN NewsFeed) -- Alphatec Holdings, Inc. (Nasdaq:ATEC ), the parent company of Alphatec Spine, Inc., a medical devic... Devices, PersonnelAlphatec Holdings (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411869 Wed, 16 Nov 2011 13:22:18 +0100 5411869 Misonix Announces New Distribution Agreement for Thailand http://www.medworm.com/index.php?rid=5411870&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034134 FARMINGDALE, N.Y. , Nov. 16, 2011 (HSMN NewsFeed) -- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic sur... Devices, DistributionMisonix, JPL Medical Co, BoneScalpel, Ultrasonic Bone Cutter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411870 Wed, 16 Nov 2011 13:19:32 +0100 5411870 Boston Scientific's WATCHMAN(R) Device Implanted in First Patients in Latin America http://www.medworm.com/index.php?rid=5411871&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034133 Innovative left atrial appendage closure device offers proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke NATICK, Mass. , Nov. 16, 2011 (HSMN NewsFeed) -- Boston Scientific Corporation's (NYSE: BSX ) ... Devices, CardiologyBoston Scientific, WATCHMAN, Left Atrial Appendage Closure Device (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411871 Wed, 16 Nov 2011 13:17:14 +0100 5411871 Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer http://www.medworm.com/index.php?rid=5411872&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034132 SAN DIEGO , Nov. 15, 2011 (HSMN NewsFeed) -- Ambit Biosciences Inc. today announced the appointment of Michael A. Martino as President, Chief Executive Officer and member of the Board of Directors. Martino brings to Ambit a nearly 30-year track record in... Biopharmaceuticals, PersonnelAmbit Biosciences (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411872 Wed, 16 Nov 2011 13:13:43 +0100 5411872 CorMatrix Receives Full IDE Approval for the Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Patients Receiving the CorMatrix(R) ECM(R) for Pericardial Closure http://www.medworm.com/index.php?rid=5411873&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034131 ATLANTA , Nov. 16, 2011 (HSMN NewsFeed) -- CorMatrix Cardiovascular, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company full IDE approval for its ongoing multi-center, prospective, randomized clinical trial aimi... Devices, CardiologyCorMatrix Cardiovascular, CorMatrix ECM, extracellular matrix (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411873 Wed, 16 Nov 2011 13:11:37 +0100 5411873 Allena Pharmaceuticals Launches with $15 Million Series A Round http://www.medworm.com/index.php?rid=5411874&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034130 Company Developing Non-Systemic Protein Therapeutics for Metabolic Disorders; Founded by Proven Management Team & Funded by Top-Tier Life Sciences VCs NEWTON, Mass.--(Healthcare Sales & Marketing Network)-- Allena Pharmaceuticals, Inc., a company develo... Biopharmaceuticals, Venture CapitalAllena Pharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411874 Wed, 16 Nov 2011 13:08:07 +0100 5411874 Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy http://www.medworm.com/index.php?rid=5411875&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034129 AMSTERDAM , November 16, 2011 (HSMN NewsFeed) -- Amsterdam Molecular Therapeutics (Euronext: AMT ), a leader in the field of human gene therapy, announced today that the European Medicines Agency (EMA) has granted orphan designation for its gene therapy ... Biopharmaceuticals, RegulatoryAmsterdam Molecular Therapeutics, hemophilia B, factor IX gene, gene therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411875 Wed, 16 Nov 2011 13:03:06 +0100 5411875 The Cooper Companies Announces Its Subsidiary CooperVision Has Expanded Its Recall to Include the Replacement of Limited Lots of Avaira Sphere http://www.medworm.com/index.php?rid=5411876&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034128 PLEASANTON, Calif., Nov. 15, 2011 --(HSMN NewsFeed) -- The Cooper Companies, Inc. (NYSE:COO ) today announced that its subsidiary CooperVision has expanded its recall on limited lots of Avaira(R) Toric contact lenses to include limited lots of Avaira Spher... Devices, Ophthalmology, Product RecallCooperVision, Avaira, contact lens (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5411876 Tue, 15 Nov 2011 16:56:59 +0100 5411876 Sectra Launches Support for Breast Tomosynthesis Images in PACS http://www.medworm.com/index.php?rid=5402237&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034116 At RSNA 2011 in Chicago , international medical imaging IT company, Sectra (NASDAQ OMX Stockholm: SECT B), will showcase support for the display and review of breast tomosynthesis images in Sectra Breast Imaging PACS. SHELTON, Connecticut , November 11,... Devices, RadiologySectra, Tomosynthesis, breast imaging, PACS , mammography (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5402237 Fri, 11 Nov 2011 12:43:21 +0100 5402237 Baxter Completes Acquisition of Baxa Corporation http://www.medworm.com/index.php?rid=5391353&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034115 DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)-- Baxter International Inc. (NYSE:BAX ) announced today that the company has completed its planned acquisition of Baxa Corporation, a privately held global company based in Englewood, Colo., for a cas... Devices, Mergers & AcquisitionsBaxter, Baxa Corp (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5391353 Thu, 10 Nov 2011 12:54:18 +0100 5391353 EDAP Generates First U.S. Sonolith i-move Lithotripter Sale http://www.medworm.com/index.php?rid=5391354&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034114 Empire Litho to Utilize Compact Lithotripter on Mobile Basis at Six New York City Metro Hospitals US Sale Recorded Three Months Following U.S. FDA 510(k) Clearance LYON, France, Nov. 10, 2011 --(HSMN NewsFeed) -- EDAP TMS SA (Nasdaq:EDAP ), the globa... Devices, UrologyEDAP TMS, Sonolith i-move, lithotripter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5391354 Thu, 10 Nov 2011 12:50:55 +0100 5391354 Merge Healthcare Names Two New Senior Executives http://www.medworm.com/index.php?rid=5391355&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034113 Industry veterans to grow partner sales; lead solutions management team CHICAGO--(Healthcare Sales & Marketing Network)-- Merge Healthcare (NASDAQ: MRGE ), a leading provider of enterprise imaging and interoperability solutions, today announced the addi... Devices, PersonnelMerge Healthcare (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5391355 Thu, 10 Nov 2011 12:46:33 +0100 5391355 Cerebral Stethoscope Offers New Tool for Early Detection of Aneurysms http://www.medworm.com/index.php?rid=5391356&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034111 ALPINE, N.J., Nov. 9, 2011 (HSMN NewsFeed) -- ProTron Technologies announces a new approach to early detection of aneurysms in vascular systems through the patented Stethotron® Cerebral Stethoscope. In the USA alone, six million people have a brai... DevicesProTron Technologies, Stethotron, Cerebral Stethoscope, aneurysm (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5391356 Wed, 09 Nov 2011 16:14:43 +0100 5391356 Tangent Medical Closes $4.5 Million Series A Financing http://www.medworm.com/index.php?rid=5367636&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034086 ANN ARBOR, Mich.--(Healthcare Sales & Marketing Network)-- Tangent Medical Technologies, Inc., a development stage medical device company, announced the completion of a $4.5 million Series A equity financing co-led by Arboretum Ventures (Ann Arbor, MI) and... Devices, Venture Capital, PersonnelTangent Medical Technologies, NovaCath, Closed IV Catheter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5367636 Thu, 03 Nov 2011 16:40:00 +0100 5367636 Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance(R) Drug Eluting Balloon with Paccocath(R) Technology to be Presented at 2011 TCT http://www.medworm.com/index.php?rid=5367637&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034085 Data represent first five-year evaluation of target lesion revascularization rates with Cotavance balloon catheter compared to standard balloon angioplasty in PAD patients WARRENDALE, Pa., Nov. 3, 2011 (HSMN NewsFeed) -- MEDRAD Interventional, a busi... Devices, InterventionalMEDRAD, Bayer HealthCare, Cotavance, Drug Eluting Balloon (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5367637 Thu, 03 Nov 2011 16:37:48 +0100 5367637 K2M Announces Global Launch of CHESAPEAKE(R) Anterior-Lumbar Stabilization System at 2011 North American Spine Society Annual Meeting http://www.medworm.com/index.php?rid=5367638&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034084 LEESBURG, Va.--(Healthcare Sales & Marketing Network)-- K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the global launch of the latest pr... Devices, Orthopaedic, NeurosurgeryK2M, CHESAPEAKE Stabilization System, spinal surgery (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5367638 Thu, 03 Nov 2011 16:34:27 +0100 5367638 Sarah Schiltz Named VP of Marketing at Atherotech Diagnostics Lab http://www.medworm.com/index.php?rid=5350639&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034032 Move strengthens management team, positions company for future growth BIRMINGHAM, Ala.--(Healthcare Sales & Marketing Network)-- Atherotech Diagnostics Lab has named Sarah Schiltz to the newly created position of vice president of marketing. Schiltz bri... Diagnostics, PersonnelAtherotech Diagnostics (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5350639 Wed, 26 Oct 2011 21:47:21 +0100 5350639 St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System http://www.medworm.com/index.php?rid=5350640&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034031 ILUMIEN system assists physicians in optimizing interventional coronary treatment strategies ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)-- St. Jude Medical, Inc. (NYSE:STJ ), a global medical device company, today announced it has received U... Devices, CardiolgoySt. Jude Medical, ILUMIEN system, optical coherence tomography, FFR (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5350640 Wed, 26 Oct 2011 21:44:38 +0100 5350640 Mylan Announces New, Expanded Management Structure to be Effective Jan. 1, 2012 http://www.medworm.com/index.php?rid=5350641&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034030 Robert J. Coury to Transition to Role of Executive Chairman Heather Bresch Promoted to Chief Executive Officer Rajiv Malik Promoted to President; Hal Korman to Chief Operating Officer; Tony Mauro to President, North America PITTSBURGH, Oct. 26, 20... Biopharmaceuticals, PersonnelMylan (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5350641 Wed, 26 Oct 2011 21:37:20 +0100 5350641 Angiotech Pharmaceuticals, Inc. announces senior staff changes http://www.medworm.com/index.php?rid=5339072&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034012 VANCOUVER, Oct. 21, 2011 (HSMN NewsFeed) - Angiotech Pharmaceuticals, Inc. today announced changes to its senior management team. Dr. William Hunter will no longer serve as Angiotech's President and CEO, and Thomas Bailey, Angiotech's Chief Financial Of... Biopharmaceuticals, PersonnelAngiotech Pharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5339072 Fri, 21 Oct 2011 13:02:20 +0100 5339072 Teleflex Signs Definitive Agreement to Sell Aerospace Businesses for $280 Million http://www.medworm.com/index.php?rid=5339073&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034011 LIMERICK, Pa.--(Healthcare Sales & Marketing Network)-- Teleflex Incorporated (NYSE:TFX ), a leading global provider of medical technology products, today announced that it has entered into a definitive agreement to sell its cargo systems and container aer... DevicesTeleflex (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5339073 Fri, 21 Oct 2011 12:59:59 +0100 5339073 Teleflex Incorporated Signs New Agreement with Premier for Arrow(R) Intra-Aortic Balloon Catheter and Pump (IABP) Products http://www.medworm.com/index.php?rid=5339074&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034010 LIMERICK, Pa.--(Healthcare Sales & Marketing Network)-- Teleflex Incorporated (NYSE:TFX ), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with Premier Purchasing Partners, L.P., the group purchasin... Devices, Cardiology, Group PurchasingTeleflex, Premier Purchasing, Arrow, Intra-Aortic Balloon (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5339074 Fri, 21 Oct 2011 12:57:26 +0100 5339074 RaySearch Laboratories: New York Hospital Selects RayStation(R) for Advanced Research http://www.medworm.com/index.php?rid=5339075&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034009 STOCKHOLM--(Healthcare Sales & Marketing Network)-- RaySearch Laboratories AB (STO:RAYB.st ) has received an order for its RayStation® treatment planning system from The University Hospital of Columbia and Cornell in New York. RayStation® will serv... Devices, OncologyRaySearch Laboratories, RayStation, treatment planning system, radiotherapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5339075 Fri, 21 Oct 2011 12:54:10 +0100 5339075 Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex(R) Biliary RX Stent http://www.medworm.com/index.php?rid=5326153&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034001 NATICK, Mass., Oct. 18, 2011 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE:BSX ) has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures (narrowin... Devices, Interventional, GastroenterologyBoston Scientific, WallFlex Biliary RX Stent, biliary stent (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5326153 Tue, 18 Oct 2011 13:04:12 +0100 5326153 Wright Medical Group, Inc. Names Julie D. Tracy Senior Vice President and Chief Communications Officer http://www.medworm.com/index.php?rid=5326154&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2034000 ARLINGTON, Tenn.--(Healthcare Sales & Marketing Network)-- Wright Medical Group, Inc. (NASDAQ:WMGI ), a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today announced that Julie D. Trac... Devices, Orthopaedic, PersonnelWright Medical Group (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5326154 Tue, 18 Oct 2011 13:01:12 +0100 5326154 Lilly Announces Changes in Senior Management http://www.medworm.com/index.php?rid=5306852&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033970 Carmine, Deane retiring; Ricks, Crowe, Azar promoted INDIANAPOLIS, Oct. 11, 2011 (HSMN NewsFeed) -- Eli Lilly and Company (NYSE:LLY ) today announced key appointments due to the December 31 retirements of longtime senior leaders, Bryce D. Carmine and ... Biopharmaceuticals, PersonnelEli Lilly (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5306852 Tue, 11 Oct 2011 13:04:47 +0100 5306852 Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies http://www.medworm.com/index.php?rid=5306853&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033969 SAN FRANCISCO, Oct. 11, 2011 (HSMN NewsFeed) -- Cleave Biosciences, a newly established biopharmaceutical company discovering and developing novel therapies for cancer, announced today it has raised $42 million in Series A financing. Cleave Biosciences w... Biopharmaceuticals, Oncology, Venture CapitalCleave Biosciences (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5306853 Tue, 11 Oct 2011 13:01:24 +0100 5306853 iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities http://www.medworm.com/index.php?rid=5306854&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033968 MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)-- iScience Interventional (iScience, Menlo Park, CA), pioneers of site-specific therapies for anterior and posterior ocular diseases, today announced an investment by Medtronic Inc. to support rapi... Devices, Ophthalmology, InterventionaliScience Interventional, Medtronic, microcatheter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5306854 Tue, 11 Oct 2011 12:58:29 +0100 5306854 Echo Therapeutics Hires Product Development Management Executive http://www.medworm.com/index.php?rid=5306855&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033967 PHILADELPHIA, Oct. 11, 2011 (HSMN NewsFeed) -- Echo Therapeutics, Inc. (Nasdaq:ECTE ), a company developing the Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep S... Devices, Monitoring, PersonnelEcho Therapeutics, Symphony tCGM (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5306855 Tue, 11 Oct 2011 12:54:34 +0100 5306855 Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer http://www.medworm.com/index.php?rid=5306856&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033966 CEO brings more than 20 years' experience commercializing innovative therapies, with expertise leading businesses serving rare disease patient populations LAGUNA NIGUEL, Calif., Oct. 11, 2011 (HSMN NewsFeed) -- Inspiration Biopharmaceuticals, Inc. (In... Biopharmaceuticals, PersonnelInspiration Biopharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5306856 Tue, 11 Oct 2011 12:52:04 +0100 5306856 Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier http://www.medworm.com/index.php?rid=5306857&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033965 ASHBURN, Va., Oct. 11, 2011 (HSMN NewsFeed) -- Innocoll, Inc. announces the approval of CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. The product will be launched this year thro... Devices, Surgery, RegulatoryInnocoll, CollaGUARD, surgical adhesion barrier (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5306857 Tue, 11 Oct 2011 12:48:56 +0100 5306857 Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH http://www.medworm.com/index.php?rid=5298663&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033954 Cialis for once daily use is the first and only medication approved to treat men with both ED and BPH INDIANAPOLIS, Oct. 7, 2011 (HSMN NewsFeed) -- Eli Lilly and Company (NYSE:LLY ) announced today that the U.S. Food and Drug Administration (FDA) has ... BiopharmaceuticalsEli Lilly, Cialis, tadalafil, erectile dysfunction, benign prostatic hyperplasia (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5298663 Fri, 07 Oct 2011 12:46:09 +0100 5298663 D. Medical Expands U.S. Distribution Network for Spring Universal Infusion Sets http://www.medworm.com/index.php?rid=5288353&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033953 TIRAT CARMEL, Israel, Oct. 6, 2011 --(HSMN NewsFeed) -- D. Medical Industries Ltd. (Nasdaq:DMED ) (TASE:DMED ) ("D. Medical" or the "Company"), a medical device company engaged through its subsidiaries in the research, development, manu... Devices, DistributionD. Medical Industries, Spring Health, Doubek Medical Supply, Infusion Sets (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5288353 Thu, 06 Oct 2011 12:38:26 +0100 5288353 William A. Hawkins Appointed New CEO of Immucor http://www.medworm.com/index.php?rid=5288354&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033952 ATLANTA, Oct. 6, 2011 --(HSMN NewsFeed) -- The Board of Directors of Immucor, Inc. announced today that William A. Hawkins will be Immucor's next CEO. Immucor, Inc. is a private company, wholly owned by TPG Capital. Mr. Hawkins' appointment follows the dec... Diagnostics, PersonnelImmucor (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5288354 Thu, 06 Oct 2011 12:34:41 +0100 5288354 Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony(R) Continuous Glucose Monitoring System http://www.medworm.com/index.php?rid=5288355&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033951 PHILADELPHIA, Oct. 6, 2011 (HSMN NewsFeed) -- Echo Therapeutics, Inc. (Nasdaq:ECTE ), a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System ... Devices, MonitoringEcho Therapeutics, Symphony tCGM, continuous glucose monitoring (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5288355 Thu, 06 Oct 2011 12:31:11 +0100 5288355 Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer http://www.medworm.com/index.php?rid=5276942&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033935 BURLINGTON, Mass., Oct. 3, 2011 (HSMN NewsFeed) -- Coronado Biosciences, Inc. today announced the appointment of Noah D. Beerman as Executive Vice President and Chief Operating Officer effective September 26, 2011. Dr. Bobby W. Sandage, Jr., Coronado's... Biopharmaceuticals, PersonnelCoronado Biosciences (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276942 Mon, 03 Oct 2011 17:44:44 +0100 5276942 GETINGE GROUP and Subsidiary MAQUET Cardiovascular Sign Agreement to Acquire Atrium Medical for $680 Million http://www.medworm.com/index.php?rid=5276943&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033934 Atrium's products strategically augment MAQUET Cardiovascular's global business WAYNE, N.J., Oct. 3, 2011 (HSMN NewsFeed) -- GETINGE GROUP (STO:GETIB.st ) and its subsidiary, MAQUET Cardiovascular, a global leading provider of cardiovascular technolog... Devices, Mergers & AcquisitionsMAQUET Cardiovascular, GETINGE GROUP, Atrium Medical (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276943 Mon, 03 Oct 2011 13:39:58 +0100 5276943 Varian Medical Systems Books $88 Million Order to Equip Proton Treatment Center http://www.medworm.com/index.php?rid=5276944&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033933 PALO ALTO, Calif., Oct. 3, 2011 (HSMN NewsFeed) -- Varian Medical Systems (NYSE:VAR ) today announced it has booked an $88 million order to provide its ProBeam system for the Scripps Proton Therapy Center being developed in San Diego through collaboratio... Devices, OncologyVarian Medical Systems, ProBeam system, Proton Therapy, particle therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276944 Mon, 03 Oct 2011 13:37:22 +0100 5276944 Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand http://www.medworm.com/index.php?rid=5276945&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033932 Non-Invasive Medical Device Providing a Validated Treatment Alternative for Patients with Obstructive Sleep Apnea (OSA) BELMONT, Calif. and BRISBANE, Australia, Oct. 3, 2011 (HSMN NewsFeed) -- Ventus Medical is pleased to announce that its proprietary... DevicesVentus Medical, Provent, Sleep Apnea Therapy, obstructive sleep apnea (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276945 Mon, 03 Oct 2011 13:33:56 +0100 5276945 The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva http://www.medworm.com/index.php?rid=5276946&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033931 PARSIPPANY, NJ--(Healthcare Sales & Marketing Network)- The Medicines Company (NASDAQ: MDCO ) today announced that it has settled the lawsuits filed by MDCO in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Applic... Biopharmaceuticals, LitigationThe Medicines Company, MDCO, Teva Pharmaceuticals, Angiomax, bivalirudin (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276946 Mon, 03 Oct 2011 13:29:03 +0100 5276946 Integra LifeSciences Meets Surgeon Demand for User-Friendly Minimally Invasive Spinal Solutions http://www.medworm.com/index.php?rid=5276947&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033930 Expanded Product Offering With Two New Systems PLAINSBORO, N.J., Oct. 3, 2011 --(HSMN NewsFeed) -- Integra LifeSciences (Nasdaq:IART ) today announced the global market introduction of the NewPort(TM) Minimally Invasive Spinal System (MIS) and the limit... Devices, Neurosurgery, OrthopaedicIntegra LifeSciences, NewPort, Minimally Invasive Spinal System, spine surgery (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276947 Mon, 03 Oct 2011 13:22:11 +0100 5276947 Integra LifeSciences Launches Integra(TM) CUSA NXT(TM) Extended Length Tip at 2011 Congress of Neurological Surgeons Annual Meeting http://www.medworm.com/index.php?rid=5276948&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033929 New Tip Expands Applications for CUSA NXT(TM) and CUSA Selector(R) Ultrasonic Tissue Ablation Systems PLAINSBORO, N.J., Oct. 3, 2011 --(HSMN NewsFeed) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART ) today announced the launch of the IntegraT... Devices, NeurosurgeryIntegra LifeSciences, CUSA NXT, Ultrasonic Tissue Ablation Systems, CUSA system (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276948 Mon, 03 Oct 2011 13:15:21 +0100 5276948 Atrium Medical Agrees To Be Acquired for $680 Million by GETINGE GROUP http://www.medworm.com/index.php?rid=5276949&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033928 HUDSON, N.H., Oct. 3, 2011 (HSMN NewsFeed) -- Atrium Medical Corporation, announced today that it has signed a definitive agreement to be acquired by GETINGE GROUP (STO:GETIB.st ) of Sweden and its subsidiary, MAQUET Cardiovascular, a global leading prov... Devices, Mergers & AcquisitionsAtrium Medical, GETINGE GROUP, MAQUET Cardiovascular (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276949 Mon, 03 Oct 2011 13:11:47 +0100 5276949 RaySearch Laboratories AB: Florida hospital selects RayStation(R) http://www.medworm.com/index.php?rid=5276950&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033927 STOCKHOLM--(Healthcare Sales & Marketing Network)-- RaySearch Laboratories AB (STO:RAYB.st ) has received an order for its RayStation® treatment planning system from Baptist Hospital of Miami. Baptist Hospital of Miami is a part of Baptist Health So... Devices, OncologyRaySearch Laboratories, RayStation, treatment planning system, IMRT, VMAT (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276950 Mon, 03 Oct 2011 13:07:25 +0100 5276950 Elekta Divests Its Anatomic Pathology Information System http://www.medworm.com/index.php?rid=5276951&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033926 STOCKHOLM--(Healthcare Sales & Marketing Network)-- Elekta AB (publ) (STO:EKTAB.st ) today announced it has divested its Anatomic Pathology Information System business, marketed under the brand name PowerPath®, a software line that manages workflow for... DevicesElekta, PowerPath, Sunquest Information Systems (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5276951 Mon, 03 Oct 2011 13:03:18 +0100 5276951 Biogen Idec Promotes Tony Kingsley to Run Global Commercial Operations http://www.medworm.com/index.php?rid=5263698&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033919 Has been instrumental in reinvigorating U.S. Commercial Operations WESTON, Mass.--(Healthcare Sales & Marketing Network)-- Biogen Idec (NASDAQ:BIIB ) today announced that Tony Kingsley has been promoted to Executive Vice President, Global Commercial Ope... Biopharmaceuticals, PersonnelBiogen Idec (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5263698 Thu, 29 Sep 2011 12:56:18 +0100 5263698 Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors http://www.medworm.com/index.php?rid=5253336&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033896 EXTON, Pa., Sept. 23, 2011 (HSMN NewsFeed) -- Kensey Nash Corporation (Nasdaq:KNSY ) today announced that Lisa Earnhardt, President and Chief Executive Officer of Intersect ENT, has joined Kensey Nash's Board of Directors. Ms. Earnhardt has served as ... Devices, Regenerative Medicine, PersonnelKensey Nash (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5253336 Fri, 23 Sep 2011 19:41:41 +0100 5253336 Scott Solano to Depart AngioDynamics http://www.medworm.com/index.php?rid=5253337&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033895 ALBANY, N.Y.--(Healthcare Sales & Marketing Network)-- AngioDynamics (NASDAQ:ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano, S... Devices, PersonnelAngioDynamics (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5253337 Fri, 23 Sep 2011 19:39:16 +0100 5253337 Cambridge Heart Announces Agreement to Distribute Its HearTwave II System in Singapore http://www.medworm.com/index.php?rid=5241215&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033894 TEWKSBURY, Mass.--(Healthcare Sales & Marketing Network)-- Cambridge Heart, Inc. (OTCBB:CAMH.ob ), a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to dist... Devices, Cardiology, DistributionCambridge Heart, EO Medical Pte Ltd, HearTwave II, Microvolt T-Wave Alternans (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5241215 Thu, 22 Sep 2011 13:01:02 +0100 5241215 Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer http://www.medworm.com/index.php?rid=5241216&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033893 Chen Schor Joins as Chief Business Officer Industry Veterans Build on Company Expertise as Lead Program Moves into Development CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)-- Eleven Biotherapeutics, a biopharmaceutical company focused on e... Biopharmaceuticals, PersonnelEleven Biotherapeutics (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5241216 Thu, 22 Sep 2011 12:58:27 +0100 5241216 Viking Systems, Inc. Announces New Alliances for Selling Its 3DHD Vision Systems in the USA http://www.medworm.com/index.php?rid=5241217&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033892 WESTBOROUGH, Mass., Sept. 22, 2011 --(HSMN NewsFeed) -- Viking Systems, Inc. (OTCBB:VKNG.OB ), a leading worldwide developer, manufacturer and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery, today announced changes to ... Devices, DistributionViking Systems, 3DHD Vision Systems (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5241217 Thu, 22 Sep 2011 12:56:00 +0100 5241217 Life Technologies Signs Agreement with Quidel to Distribute and Commercialize Diagnostic Assays in Europe http://www.medworm.com/index.php?rid=5241218&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033891 Life to Commercialize Influenza Assay for Use on the 7500 Series of Instruments CARLSBAD, Calif., Sept. 22, 2011 (HSMN NewsFeed) -- Life Technologies Corporation (NASDAQ:LIFE ) today announced that the company has signed an agreement with Quidel Corpo... Diagnostics, DistributionLife Technologies Corp, Quidel (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5241218 Thu, 22 Sep 2011 12:50:44 +0100 5241218 Sapheon Receives CE Mark Approval for New Varicose Vein Treatment http://www.medworm.com/index.php?rid=5241219&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033890 SANTA ROSA, Calif.--(Healthcare Sales & Marketing Network)-- Sapheon Inc. announced that it has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease. The Sapheon Closure System addresses the esti... Devices, RegulatorySapheon, Sapheon Closure System (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5241219 Thu, 22 Sep 2011 12:46:17 +0100 5241219 Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company http://www.medworm.com/index.php?rid=5228963&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033862 Acquisition expected to add $0.08 to 2012 non-GAAP Earnings Per Share SAN CARLOS, Calif.--(Healthcare Sales & Marketing Network)-- Natus Medical Incorporated (Nasdaq:BABY ) today announced that it has acquired Embla Systems LLC, a leader in the developm... Devices, Mergers & AcquisitionsNatus Medical, Embla Systems, Polysomnography (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5228963 Fri, 16 Sep 2011 12:41:44 +0100 5228963 Medtronic Announces 510(k) Clearance for the TSRH(R) Spinal System Pedicle Screw for the Treatment of Adolescent Idiopathic Scoliosis http://www.medworm.com/index.php?rid=5228964&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033861 AIS is the Most Common Type of Scoliosis Seen in Adolescents and Affects Nearly One Million Adolescents in the U.S. Alone MEMPHIS, Tenn.--(Healthcare Sales & Marketing Network)-- Medtronic (NYSE:MDT ) announced today it received a second clearance from ... Devices, Orthopaedic, Neurosurgery, FDAMedtronic, TSRH Spinal System, Pedicle Screw, adolescent idiopathic scoliosis (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5228964 Thu, 15 Sep 2011 22:26:33 +0100 5228964 Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer http://www.medworm.com/index.php?rid=5212855&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033835 AUSTIN, Texas, Sept. 12, 2011 (HSMN NewsFeed) -- Hanger Orthopedic Group, Inc. today announced the appointment of Vinit K. Asar to President and Chief Operating Officer, effective immediately. Mr. Asar joined the company in December 2008 as Executive Vi... Devices, Orthopaedic, PersonnelHanger Orthopedic Group (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5212855 Mon, 12 Sep 2011 23:56:36 +0100 5212855 FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development http://www.medworm.com/index.php?rid=5212856&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033834 SAN FRANCISCO--(Healthcare Sales & Marketing Network)-- FibroGen, Inc., today announced the appointment of Michael Martinelli, Ph.D., as Vice President, Technical Development. In this role, Dr. Martinelli is responsible for the chemistry, manufacturing, an... Biopharmaceuticals, PersonnelFibroGen (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5212856 Mon, 12 Sep 2011 23:53:44 +0100 5212856 Medtronic Announces Launch of ARTISAN(TM) Space Maintenance System http://www.medworm.com/index.php?rid=5212857&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033833 New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications MEMPHIS, Tenn.--(Healthcare Sales & Marketing Network)-- Medtronic, Inc. (NYSE:MDT ) announced today the U.S. launch of its ARTI... Devices, OrthopaedicMedtronic, ARTISAN, Space Maintenance System, bone graft (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5212857 Mon, 12 Sep 2011 23:51:33 +0100 5212857 Immunovaccine Announces Appointment of John Trizzino as CEO http://www.medworm.com/index.php?rid=5212858&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033832 HALIFAX, NOVA SCOTIA--(Healthcare Sales & Marketing Network)- Immunovaccine Inc. (TSX-V: IMV.V ), a vaccine development company, announced today the appointment of John J. Trizzino as Chief Executive Officer, effective October 1, 2011. Mr. Trizzino will al... Biopharmaceuticals, PersonnelImmunovaccine, vaccine (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5212858 Mon, 12 Sep 2011 16:18:31 +0100 5212858 MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM http://www.medworm.com/index.php?rid=5198633&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033808 IRVINE, Calif.--(Healthcare Sales & Marketing Network)-- MiCardia Corporation, a privately held medical device company, announced today that it has received the CE-Mark approval for commercial sales of its enCorSQ Mitral Valve Repair System in Europe and s... Devices, Cardiology, RegulatoryMiCardia, enCorSQ, Mitral Valve Repair System, Mitral Regurgitation (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198633 Thu, 08 Sep 2011 02:12:34 +0100 5198633 Rib-X Announces Senior Management Promotions http://www.medworm.com/index.php?rid=5198634&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033807 NEW HAVEN, Conn.--(Healthcare Sales & Marketing Network)-- Rib-X Pharmaceuticals, Inc., a development-stage company with an industry leading pipeline of broad spectrum antibiotics, today announced the promoti... Biopharmaceuticals, PersonnelRib-X Pharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198634 Wed, 07 Sep 2011 19:50:10 +0100 5198634 Cornerstone Therapeutics Appoints New President http://www.medworm.com/index.php?rid=5198635&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033806 CARY, NC--(Healthcare Sales & Marketing Network)- Cornerstone Therapeutics Inc. (NASDAQ: CRTX ), a specialty pharmaceutical company focused on developing, acquiring and commercializing products for the respiratory, hospital and related specialty markets, t... Biopharmaceuticals, PersonnelCornerstone Therapeutics (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198635 Wed, 07 Sep 2011 19:29:48 +0100 5198635 iPierian Appoints Nancy Stagliano as CEO; Peter Van Vlasselaer, Interim CEO, Becomes Executive Chairman of the Board http://www.medworm.com/index.php?rid=5198636&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033805 SAN FRANCISCO--(Healthcare Sales & Marketing Network)-- iPierian, Inc., announced today that it has appointed Nancy E. Stagliano, PhD as its Chief Executive Officer. The company’s interim CEO, Peter Van Vlasselaer, PhD will become Executive Chairman of the... Biopharmaceuticals, PersonneliPierian (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198636 Wed, 07 Sep 2011 19:22:53 +0100 5198636 OptiMedica Receives CE Mark for Catalys(TM) Precision Laser System http://www.medworm.com/index.php?rid=5198637&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033804 SANTA CLARA, Calif.--(Healthcare Sales & Marketing Network)-- Global ophthalmic company OptiMedica Corp. has announced that it has received CE mark approval to market its Catalys Precision Laser System for cataract surgery in Europe. Catalys combines a fem... Devices, Ophthalmology, RegulatoryOptiMedica Corp, femtosecond laser, Catalys , Optical Coherence Tomography (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198637 Wed, 07 Sep 2011 12:58:31 +0100 5198637 Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study http://www.medworm.com/index.php?rid=5198638&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033803 Safety Profile Consistent with Clinical Trials MALVERN, Pa., Sept. 7, 2011 (HSMN NewsFeed) -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL ), a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study ... BiopharmaceuticalsAuxilium Pharmaceuticals, XIAFLEX, Dupuytren's contracture (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198638 Wed, 07 Sep 2011 12:53:53 +0100 5198638 TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia http://www.medworm.com/index.php?rid=5198639&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033802 SAN DIEGO--(Healthcare Sales & Marketing Network)-- TrovaGene, Inc. (Pink Sheets:TROV.pk ), a developer of transrenal molecular diagnostics to facilitate personalized medicine, has signed a worldwide exclusive license for an assay that detects Hairy Cell L... Diagnostics, Licensing, OncologyTrovaGene, Hairy Cell Leukemia, BRAF gene (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198639 Wed, 07 Sep 2011 12:48:37 +0100 5198639 St. Jude Medical Announces European Regulatory Approval of First Implanted Neurostimulation Device to Treat Chronic Migraine http://www.medworm.com/index.php?rid=5198640&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033801 CE Mark approval expands treatment options for patients suffering from the pain and disability associated with intractable chronic migraine ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)-- St. Jude Medical, Inc. (NYSE:STJ ), a global medical de... Devices, RegulatorySt. Jude Medical, neurostimulation, migraine, Genesis (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198640 Wed, 07 Sep 2011 12:44:42 +0100 5198640 MELA Sciences Receives European Union Approval for MelaFind(R) http://www.medworm.com/index.php?rid=5198641&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033800 Company Plans to Initially Launch MelaFind in Germany IRVINGTON, NY--(Healthcare Sales & Marketing Network)- MELA Sciences (NASDAQ: MELA ) today announced that it received CE Mark approval for MelaFind®, allowing the company to market its MelaFind d... Devices, Oncology, RegulatoryMELA Sciences, MelaFind, melanoma (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198641 Wed, 07 Sep 2011 00:16:21 +0100 5198641 Savient Announces the Election of William F. Owen, Jr., M.D. and David Y. Norton to its Board of Directors http://www.medworm.com/index.php?rid=5198642&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033799 EAST BRUNSWICK, N.J., Sept. 6, 2011 (HSMN NewsFeed) -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that William F. Owen, Jr., M.D. and David Y. Norton have been elected to the Company's Board of Directors, effective September 1, 2011. ... Biopharmaceuticals, PersonnelSavient Pharmaceuticals, KRYSTEXXA, pegloticase, gout (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198642 Tue, 06 Sep 2011 20:07:43 +0100 5198642 NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD(R) and ResQPump) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest http://www.medworm.com/index.php?rid=5198643&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033797 ROSEVILLE, Minn., Sept. 6, 2011 (HSMN NewsFeed) -- Today, Advanced Circulatory Systems Inc. (ACSI) announced results from a large, NIH-funded clinical trial comparing standard cardiopulmonary resuscitation (CPR) to a new method of CPR that provides great... Devices, CardiologyAdvanced Circulatory Systems, ResQCPR, ResQPump, ResQPOD, CPR (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198643 Tue, 06 Sep 2011 16:20:30 +0100 5198643 ViroPharma's Buccolam(R) (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures http://www.medworm.com/index.php?rid=5198644&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033796 Approval Offers Convenient Alternative to Treat Seizures in Children and Adolescents First Ever Product Approved through European Commission's Centralized Pediatric Use Marketing Authorization (PUMA) EXTON, Pa., Sept. 6, 2011 (HSMN NewsFeed) -- Vir... Biopharmaceuticals, Neurology, FDAViroPharma, Buccolam, Midazolam, seizures (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198644 Tue, 06 Sep 2011 16:15:42 +0100 5198644 FDA Clears Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present with Adnexal Mass http://www.medworm.com/index.php?rid=5198645&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033795 Fujirebio Diagnostics' ROMA (HE4 EIA + ARCHITECT CA 125 II) Test is New Option to Evaluate the Likelihood of Ovarian Cancer MALVERN, Pa., Sept. 6, 2011 (HSMN NewsFeed) -- Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announ... Diagnostics, Oncology, FDAFujirebio Diagnostics, ROMA test, ovarian cancer (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198645 Tue, 06 Sep 2011 16:12:25 +0100 5198645 Hemosphere Receives CE Mark Approval for the HeRO(R) Graft http://www.medworm.com/index.php?rid=5198646&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033794 Opens European Union Market for Future Growth Opportunities Building Upon HeRO® Graft’s Success in the United States EDEN PRAIRIE, Minn.--(Healthcare Sales & Marketing Network)-- Hemosphere, Inc. announced today that it has received CE Mark and ISO ... Devices, RegulatoryHemosphere, HeRO Graft, vascular access graft, hemodialysis (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198646 Tue, 06 Sep 2011 16:08:39 +0100 5198646 Restoration Robotics Promotes Mohan Bodduluri to Chief Technology Officer http://www.medworm.com/index.php?rid=5198647&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033793 New Role Will Help to Further Advance ARTAS System Technology MOUNTAIN VIEW, Calif.--(Healthcare Sales & Marketing Network)-- Restoration Robotics, Inc. a privately-held medical device company, today announced the promotion of one of its founders, Mohan... Devices, PersonnelRestoration Robotics, ARTAS System, hair transplantation (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198647 Tue, 06 Sep 2011 16:05:31 +0100 5198647 Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Hemostasis and Compression Products http://www.medworm.com/index.php?rid=5198648&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033792 CHARLOTTE, N.C.--(Healthcare Sales & Marketing Network)-- The Premier healthcare alliance today announced that new agreements for hemostasis and compression products has been awarded to Cardinal Health 200 LLC of McGaw Park, Ill.; TZ Medical Inc. of Portla... Devices, Group PurchasingPremier Purchasing, Cardinal Health, TZ Medical, Z-Medica, hemostasis (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198648 Tue, 06 Sep 2011 16:02:20 +0100 5198648 Oceana Therapeutics Announces U.S. Launch of Solesta(R), The Only Nonsurgical FDA Approved Treatment for Patients Who Fail Conservative Therapy for Fecal (Bowel) Incontinence http://www.medworm.com/index.php?rid=5198649&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033791 EDISON, N.J.--(Healthcare Sales & Marketing Network)-- Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the U.S. launch of Solesta®*, a significant new trea... DevicesOceana Therapeutics, Solesta, hyaluronic acid, fecal incontinence (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198649 Tue, 06 Sep 2011 15:59:29 +0100 5198649 DelMar Pharmaceuticals Receives FDA IND Approval to Begin Clinical Trials With A New Brain Cancer Treatment http://www.medworm.com/index.php?rid=5198650&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033790 VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network)- DelMar Pharma today announced that its investigational new drug (IND) application has been allowed by the United States Food and Drug Administration (FDA). The Company is now able to init... Biopharmaceuticals, Oncology, FDADelMar Pharmaceuticals, VAL-083, glioblastoma multiforme (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198650 Tue, 06 Sep 2011 15:54:41 +0100 5198650 AngioScore Launches New 100 mm AngioSculpt(R) Scoring Balloon Catheters for Treatment of Peripheral Artery Disease http://www.medworm.com/index.php?rid=5198651&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033789 FREMONT, Calif.--(Healthcare Sales & Marketing Network)-- AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm AngioSculpt PTA Scoring Balloon Catheter... Devices, InterventionalAngioScore, AngioSculpt, Scoring Balloon Catheter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198651 Tue, 06 Sep 2011 15:35:41 +0100 5198651 Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update http://www.medworm.com/index.php?rid=5198652&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033788 Safety Profile Consistent with Clinical Trials after Approximately 11,000 injections administered in U.S. through June 30, 2011 MALVERN, Pa., Sept. 6, 2011 (HSMN NewsFeed) -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL ), a specialty biopharmaceutica... BiopharmaceuticalsAuxilium Pharmaceuticals, XIAFLEX, Dupuytren's contracture (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198652 Tue, 06 Sep 2011 15:32:11 +0100 5198652 Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary http://www.medworm.com/index.php?rid=5198653&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033787 TARRYTOWN, N.Y., Sept. 6, 2011 (HSMN NewsFeed) -- Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN ) today announced that Joseph J. LaRosa has been appointed Senior Vice President, General Counsel and Secretary. Mr. LaRosa will be responsible for overseeing... Biopharmaceuticals, PersonnelRegeneron Pharmaceuticals, ARCALYST (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198653 Tue, 06 Sep 2011 15:28:53 +0100 5198653 ZIOPHARM Oncology Appoints Caesar J. Belbel as Executive Vice President, Chief Legal Officer and Secretary http://www.medworm.com/index.php?rid=5198654&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033786 NEW YORK--(Healthcare Sales & Marketing Network)-- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP ), a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced that it has appointed Caesar J. Belbel, Execu... Biopharmaceuticals, Oncology, PersonnelZIOPHARM Oncology, Palifosfamide, Darinaparsin, Indibulin (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198654 Tue, 06 Sep 2011 15:26:44 +0100 5198654 Impax Laboratories Appoints Carole Ben-Maimon, M.D. President of Global Pharmaceuticals http://www.medworm.com/index.php?rid=5198655&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033798 HAYWARD, Calif., Sep 06, 2011 (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today the appointment of Carole Ben-Maimon, M.D. as president of Global Pharmaceuticals, the Company's generic pharmaceutical division... Biopharmaceuticals, Drug Delivery, PersonnelImpax Laboratories (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198655 Tue, 06 Sep 2011 14:00:00 +0100 5198655 Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board http://www.medworm.com/index.php?rid=5198656&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033785 Prominent experts will guide DNA vaccines into advanced clinical stages BLUE BELL, Pa., Sept. 6, 2011 (HSMN NewsFeed) -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers ... Biopharmaceuticals, PersonnelInovio Pharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198656 Tue, 06 Sep 2011 12:23:25 +0100 5198656 New Reimbursement Codes for Intra-Operative Radiation Therapy (IORT) http://www.medworm.com/index.php?rid=5198657&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033784 Reimbursement Codes effective January 1, 2012 will cover cancer patients for additional treatment options SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)-- Friday September 2, 2011 the AMA released new Current Procedural Terminology (CPT) code... Devices, Oncology, Surgery, ReimbursementIntraOp Medical, Intraoperative radiation therapy, radiation therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5198657 Tue, 06 Sep 2011 12:19:56 +0100 5198657 EnteroMedics Announces Presentation of Maestro(R) RC System Clinical Data at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders http://www.medworm.com/index.php?rid=5186637&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033783 ST. PAUL, MN--(Healthcare Sales & Marketing Network)- EnteroMedics Inc. (NASDAQ: ETRM ), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, today announced that data f... Devices, SurgeryEnteroMedics, Maestro RC System, VBLOC-DM2 ENABLE, VBLOC Therapy (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186637 Fri, 02 Sep 2011 13:16:53 +0100 5186637 Pfizer Extends Tender Offer to Acquire Icagen, Inc. http://www.medworm.com/index.php?rid=5186638&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033782 NEW YORK and RESEARCH TRIANGLE PARK, N.C.--(Healthcare Sales & Marketing Network)-- Pfizer Inc. (NYSE:PFE ) (“Pfizer”) and Icagen, Inc. (NASDAQ:ICGN ) (“Icagen”) announced today that Pfizer’s wholly-owned subsidiary, Eclipse Acquisition Corp. (“Eclipse”), ... Biopharmaceuticals, Mergers & AcquisitionsPfizer, Icagen (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186638 Thu, 01 Sep 2011 15:18:14 +0100 5186638 Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer http://www.medworm.com/index.php?rid=5186639&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033781 SOUTH SAN FRANCISCO, Calif., Aug. 31, 2011 (HSMN NewsFeed) -- Onyx Pharmaceuticals, Inc. (Nasdaq:ONXX ) today announced that it has appointed Helen Torley, M.B. Ch. B., M.R.C.P., as Executive Vice President and Chief Commercial Officer. In her role, Dr... Biopharmaceuticals, PersonnelOnyx Pharmaceuticals (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186639 Wed, 31 Aug 2011 21:47:04 +0100 5186639 Minnetronix Names Mike Schreiber VP of Sales and Marketing http://www.medworm.com/index.php?rid=5186640&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033780 ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)-- Minnetronix, Inc., a St. Paul-based medical device design and manufacturing firm, recently announced that Mike Schreiber has joined the company as Vice President of Sales and Marketing. Schreiber... Devices, Monitoring, PersonnelMinnetronix (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186640 Wed, 31 Aug 2011 21:45:52 +0100 5186640 STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc. http://www.medworm.com/index.php?rid=5186641&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033779 MOUNTAIN VIEW, Calif., Aug. 31, 2011 (HSMN NewsFeed) -- Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced that Stryker Corporation (NYSE:SYK ) has signed a definitive agreement to acquire Concentric Medical ... Devices, Interventional, Mergers & AcquisitionsStryker, Concentric Medical, interventional neurovascular, stroke (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186641 Wed, 31 Aug 2011 21:44:03 +0100 5186641 DSM ComfortCoat(R) Hydrophilic Coating Enhances the Capabilities Of PendraCare PRIMUM Guiding Catheters http://www.medworm.com/index.php?rid=5186642&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033778 Hydrophilic coating eases catheter introduction and removal to improve patient outcomes BERKELEY, Calif.--(Healthcare Sales & Marketing Network)-- DSM, a global leader in biomedical materials science, today announced a successful collaboration with vasc... Devices, InterventionalDSM Biomedical, PendraCare, ComfortCoat, hydrophilic coating, guiding catheter (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186642 Wed, 31 Aug 2011 21:41:00 +0100 5186642 Pernix Therapeutics Appoints Steven A. Elms to Board of Directors http://www.medworm.com/index.php?rid=5186643&cid=s_35575_34_f&fid=35575&url=http%3A%2F%2Fsalesandmarketingnetwork.com%2Fnews_release.php%3FID%3D2033777 THE WOODLANDS, Texas--(Healthcare Sales & Marketing Network)-- Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company primarily focused on the pediatric market, today announced that Steven A. Elms has been appointed as a me... Biopharmaceuticals, PersonnelPernix Therapeutics (Source: HSMN NewsFeed) HSMN NewsFeed news http://www.medworm.com/rss/comments.php?id=5186643 Wed, 31 Aug 2011 21:35:22 +0100 5186643